Thomas S. Hall, chairman, president and CEO of NovaMed, along with members of the company’s management team were on hand for the event.
NovaMed currently holds majority ownership interests in 37 ASCs and is publicly traded on the Nasdaq exchange.
Read the release on NovaMed’s ringing of the Nasdaq closing bell.
